Anti-PD-1 plus anti-VEGF therapy in multiple intracranial metastases of a hypermutated, IDH wild-type glioblastoma

Neuro Oncol. 2021 Apr 12;23(4):699-701. doi: 10.1093/neuonc/noab005.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bevacizumab
  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / genetics
  • Glioblastoma* / drug therapy
  • Glioblastoma* / genetics
  • Humans
  • Isocitrate Dehydrogenase / genetics
  • Male
  • Middle Aged

Substances

  • Bevacizumab
  • Isocitrate Dehydrogenase